High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): A phase I trial.

Autor: Vestermark, Lene W., Jensen, Helle A., Pfeiffer, Per
Zdroj: Acta Oncologica. Mar2012, Vol. 51 Issue 3, p311-317. 7p.
Databáze: Academic Search Ultimate